环孢素与奥马珠单抗联合使用：慢性难治性荨麻疹的一种新选择。 - Suppr

Suppr

超能文献

Cyclosporine and omalizumab together: A new option for chronic refractory urticaria.

作者信息

Sánchez Jorge, Alvarez Leidy, Cardona Ricardo

机构信息

Group of Clinical and Experimental Allergy, IPS Universitaria, Universidad de Antioquia, Medellín, Colombia.

出版信息

J Allergy Clin Immunol Pract. 2020 Jun;8(6):2101-2103. doi: 10.1016/j.jaip.2020.02.012. Epub 2020 Feb 26.

DOI:10.1016/j.jaip.2020.02.012

PMID:32112923

Abstract

摘要

相似文献

Cyclosporine and omalizumab together: A new option for chronic refractory urticaria.

J Allergy Clin Immunol Pract. 2020 Jun;8(6):2101-2103. doi: 10.1016/j.jaip.2020.02.012. Epub 2020 Feb 26.

Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on.

Dermatol Ther. 2020 Nov;33(6):e14469. doi: 10.1111/dth.14469. Epub 2020 Nov 4.

Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):397-401. doi: 10.1016/j.anai.2017.07.029.

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.

Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.

"Omalizumab plus": Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series.

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1400-1401.e2. doi: 10.1016/j.jaip.2020.10.056. Epub 2020 Nov 9.

Chronic Urticaria.

Skinmed. 2022 Oct 31;20(4):364-366. eCollection 2022.

Chronic Urticaria.

Skinmed. 2022 Oct 31;20(5):364-366. eCollection 2022.

Omalizumab in chronic inducible urticaria: A retrospective, real-life study.

Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8.

Effective omalizumab interval prolongation in the treatment of chronic urticaria.

J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3667-3668.e1. doi: 10.1016/j.jaip.2020.06.056. Epub 2020 Jul 14.

High-dose omalizumab use in patients with chronic spontaneous urticaria.

J Allergy Clin Immunol Pract. 2020 Apr;8(4):1426-1427.e1. doi: 10.1016/j.jaip.2019.10.018. Epub 2019 Oct 31.

引用本文的文献

Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab.

Int J Dermatol. 2025 Feb;64(2):349-358. doi: 10.1111/ijd.17547. Epub 2024 Nov 3.

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases.

Allergy Asthma Clin Immunol. 2023 Aug 29;19(1):78. doi: 10.1186/s13223-023-00820-4.

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

An Bras Dermatol. 2022 Sep-Oct;97(5):592-600. doi: 10.1016/j.abd.2022.03.003. Epub 2022 Jul 16.

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.

Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211065870. doi: 10.1177/20587384211065870.

Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Clin Rev Allergy Immunol. 2021 Dec;61(3):424-448. doi: 10.1007/s12016-021-08886-x. Epub 2021 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cyclosporine and omalizumab together: A new option for chronic refractory urticaria.

J Allergy Clin Immunol Pract. 2020 Jun;8(6):2101-2103. doi: 10.1016/j.jaip.2020.02.012. Epub 2020 Feb 26.

Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on.

Dermatol Ther. 2020 Nov;33(6):e14469. doi: 10.1111/dth.14469. Epub 2020 Nov 4.

Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):397-401. doi: 10.1016/j.anai.2017.07.029.

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.

Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.

"Omalizumab plus": Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series.

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1400-1401.e2. doi: 10.1016/j.jaip.2020.10.056. Epub 2020 Nov 9.

Chronic Urticaria.

Skinmed. 2022 Oct 31;20(4):364-366. eCollection 2022.

Chronic Urticaria.

Skinmed. 2022 Oct 31;20(5):364-366. eCollection 2022.

Omalizumab in chronic inducible urticaria: A retrospective, real-life study.

Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8.

Effective omalizumab interval prolongation in the treatment of chronic urticaria.

J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3667-3668.e1. doi: 10.1016/j.jaip.2020.06.056. Epub 2020 Jul 14.

High-dose omalizumab use in patients with chronic spontaneous urticaria.

J Allergy Clin Immunol Pract. 2020 Apr;8(4):1426-1427.e1. doi: 10.1016/j.jaip.2019.10.018. Epub 2019 Oct 31.

引用本文的文献

Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab.

Int J Dermatol. 2025 Feb;64(2):349-358. doi: 10.1111/ijd.17547. Epub 2024 Nov 3.

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases.

Allergy Asthma Clin Immunol. 2023 Aug 29;19(1):78. doi: 10.1186/s13223-023-00820-4.

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

An Bras Dermatol. 2022 Sep-Oct;97(5):592-600. doi: 10.1016/j.abd.2022.03.003. Epub 2022 Jul 16.

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.

Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211065870. doi: 10.1177/20587384211065870.

Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Clin Rev Allergy Immunol. 2021 Dec;61(3):424-448. doi: 10.1007/s12016-021-08886-x. Epub 2021 Sep 16.